B16F10E-KO growth control in anti-PD-1-treated mice was associated with an increase in tumour infiltration by CD8+ T cells compared to isotype control-treated mice (Fig. 5b), and this benefit was abolished when mice received anti-CD8 blocking mAb (Fig. 5c). This evidence concerns the gene CD8A and neoplasm.